UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Highwoods Properties
HIW
$3.55B
| $6.09M | 0.01% |
156,580
-30,900
| -16% | -$1.29M |
|
952
AstraZeneca
AZN
$250B
| $6.04M | 0.01% |
84,542
+1,243
| +1% | +$91K |
|
953
Lloyds Banking Group
LYG
$91.5B
| $6.02M | 0.01% |
1,195,094
+98,103
| +9% | +$494K |
|
|
RCPT
954
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $5.94M | 0.01% |
95,700
-4,733
| -5% | -$226K |
|
|
HNT
955
DELISTED
HEALTH NET INC
HNT
| $5.94M | 0.01% |
128,762
+38,680
| +43% | +$1.72M |
|
|
GLBR
956
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $5.91M | 0.01% |
37,270
-2,638
| -7% | -$376K |
|
|
WPX
957
DELISTED
WPX Energy, Inc.
WPX
| $5.88M | 0.01% |
244,420
+5,100
| +2% | +$121K |
|
|
FOLD
958
DELISTED
Amicus Therapeutics
FOLD
| $5.87M | 0.01% |
986,000
-386,700
| -28% | -$2.03M |
|
959
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.91B
| – | – |
0
| – | – |
|
960
Nordson
NDSN
$17.4B
| $5.77M | 0.01% |
75,865
-539
| -0.7% | -$42.3K |
|
961
ING
ING
$104B
| $5.76M | 0.01% |
+406,118
| New | +$5.6M |
|
962
Ternium
TX
$10.3B
| $5.75M | 0.01% |
239,171
-313,427
| -57% | -$8.42M |
|
963
Fortune Brands Innovations
FBIN
$6.06B
| $5.75M | 0.01% |
163,595
+1,521
| +0.9% | +$53.2K |
|
|
MNDT
964
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $5.75M | 0.01% |
188,015
+18,594
| +11% | +$616K |
|
965
Texas Capital Bancshares
TCBI
$4.35B
| $5.71M | 0.01% |
98,965
-32,048
| -24% | -$1.73M |
|
966
iShares MSCI United Kingdom ETF
EWU
$4.15B
| $5.7M | 0.01% |
146,937
-44,067
| -23% | -$1.8M |
|
967
Barclays
BCS
$96.6B
| $5.69M | 0.01% |
413,175
-1,493
| -0.4% | -$20.6K |
|
968
Ciena
CIEN
$57.8B
| $5.65M | 0.01% |
337,724
-24,472
| -7% | -$480K |
|
969
Vale
VALE
$63.4B
| $5.64M | 0.01% |
511,987
-19,040
| -4% | -$254K |
|
970
America Movil
AMX
$72.5B
| $5.63M | 0.01% |
223,400
| – | – |
|
|
EOCC
971
DELISTED
Enel Generacion Chile S.A.
EOCC
| $5.6M | 0.01% |
183,949
-11,271
| -6% | -$358K |
|
|
SLXP
972
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $5.57M | 0.01% |
35,629
+400
| +1% | +$58K |
|
|
KRA
973
DELISTED
Kraton Corporation
KRA
| $5.53M | 0.01% |
310,699
| – | – |
|
|
RLYP
974
DELISTED
RELYPSA INC COM
RLYP
| $5.53M | 0.01% |
262,300
+13,000
| +5% | +$315K |
|
|
RPAI
975
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $5.44M | 0.01% |
372,029
-13,200
| -3% | -$203K |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.